Literature DB >> 30365308

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.

Huayun Shi1, Isolda Romero-Canelón1,2, Monika Hreusova3,4, Olga Novakova4, V Venkatesh1, Abraha Habtemariam1, Guy J Clarkson1, Ji-Inn Song1, Viktor Brabec4, Peter J Sadler1.   

Abstract

A series of dinuclear octahedral PtIV complexes trans, trans, trans-[{Pt(N3)2(py)2(OH)(OC(O)CH2CH2C(O)NH)}2R] containing pyridine (py) and bridging dicarboxylate [R = -CH2CH2- (1), trans-1,2-C6H10- (2), p-C6H4- (3), -CH2CH2CH2CH2- (4)] ligands have been synthesized and characterized, including the X-ray crystal structures of complexes 1·2MeOH and 4, the first photoactivatable dinuclear PtIV complexes with azido ligands. The complexes are highly stable in the dark, but upon photoactivation with blue light (420 nm), they release the bridging ligand and mononuclear photoproducts. Upon irradiation with blue light (465 nm), they generate azidyl and hydroxyl radicals, detected using a 5,5-dimethyl-1-pyrroline N-oxide electron paramagnetic resonance spin trap, accompanied by the disappearance of the ligand-to-metal charge-transfer (N3 → Pt) band at ca. 300 nm. The dinuclear complexes are photocytotoxic to human cancer cells (465 nm, 4.8 mW/cm2, 1 h), including A2780 human ovarian and esophageal OE19 cells with IC50 values of 8.8-78.3 μM, whereas cisplatin is inactive under these conditions. Complexes 1, 3, and 4 are notably more photoactive toward cisplatin-resistant ovarian A2780cis compared to A2780 cells. Remarkably, all of the complexes were relatively nontoxic toward normal cells (MRC5 lung fibroblasts), with IC50 values >100 μM, even after irradiation. The introduction of an aromatic bridging ligand (3) significantly enhanced cellular uptake. The populations in the stages of the cell cycle remained unchanged upon treatment with complexes in the dark, while the population of the G2/M phase increased upon irradiation, suggesting that DNA is a target for these photoactivated dinuclear PtIV complexes. Liquid chromatography-mass spectrometry data show that the photodecomposition pathway of the dinuclear complexes results in the release of two molecules of mononuclear platinum(II) species. As a consequence, DNA binding of the dinuclear complexes after photoactivation in cell-free media is, in several respects, qualitatively similar to that of the photoactivated mononuclear complex FM-190. After photoactivation, they were 2-fold more effective in quenching the fluorescence of EtBr bound to DNA, forming DNA interstrand cross-links and unwinding DNA compared to the photoactivated FM-190.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30365308      PMCID: PMC6257630          DOI: 10.1021/acs.inorgchem.8b02599

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  41 in total

1.  Nucleotide cross-linking induced by photoreactions of platinum(IV)-azide complexes.

Authors:  Philippe Müller; Björn Schröder; John A Parkinson; Nicole A Kratochwil; Robert A Coxall; Andrew Parkin; Simon Parsons; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2003-01-20       Impact factor: 15.336

2.  Why develop photoactivated chemotherapy?

Authors:  Sylvestre Bonnet
Journal:  Dalton Trans       Date:  2018-07-06       Impact factor: 4.390

3.  Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells.

Authors:  Jitka Pracharova; Lenka Zerzankova; Jana Stepankova; Olga Novakova; Nicola J Farrer; Peter J Sadler; Viktor Brabec; Jana Kasparkova
Journal:  Chem Res Toxicol       Date:  2012-03-28       Impact factor: 3.739

4.  Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

Authors:  Koushambi Mitra
Journal:  Dalton Trans       Date:  2016-12-06       Impact factor: 4.390

5.  Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts.

Authors:  J L van der Veer; A R Peters; J Reedijk
Journal:  J Inorg Biochem       Date:  1986-02       Impact factor: 4.155

6.  Metal complex interactions with DNA.

Authors:  Benjamin J Pages; Dale L Ang; Elisé P Wright; Janice R Aldrich-Wright
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

Review 7.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

8.  Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.

Authors:  D I Jodrell; T R J Evans; W Steward; D Cameron; J Prendiville; C Aschele; C Noberasco; M Lind; J Carmichael; N Dobbs; G Camboni; B Gatti; F De Braud
Journal:  Eur J Cancer       Date:  2004-08       Impact factor: 9.162

9.  A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer.

Authors:  Charlie Gourley; James Cassidy; Chris Edwards; Leslie Samuel; Donald Bisset; Gabriella Camboni; Anne Young; Dorothy Boyle; Duncan Jodrell
Journal:  Cancer Chemother Pharmacol       Date:  2003-11-07       Impact factor: 3.333

10.  DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.

Authors:  V Brabec; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  5 in total

1.  A visible-light photoactivatable di-nuclear PtIV triazolato azido complex.

Authors:  Kezi Yao; Arnau Bertran; Alison Howarth; Jose M Goicoechea; Samuel M Hare; Nicholas H Rees; Mohammadali Foroozandeh; Alice M Bowen; Nicola J Farrer
Journal:  Chem Commun (Camb)       Date:  2019-09-17       Impact factor: 6.222

Review 2.  Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs.

Authors:  Jingjing Huang; Weize Ding; Xingfan Zhu; Bingbing Li; Fangang Zeng; Kui Wu; Xiaoqin Wu; Fuyi Wang
Journal:  Front Chem       Date:  2022-06-09       Impact factor: 5.545

3.  Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes.

Authors:  Huayun Shi; Cinzia Imberti; Guy J Clarkson; Peter J Sadler
Journal:  Inorg Chem Front       Date:  2020-08-26       Impact factor: 6.569

4.  Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes.

Authors:  Elizabeth M Bolitho; Carlos Sanchez-Cano; Huayun Shi; Paul D Quinn; Maria Harkiolaki; Cinzia Imberti; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2021-11-22       Impact factor: 15.419

5.  Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity.

Authors:  Chaoyang Li; Fengmin Xu; Yao Zhao; Wei Zheng; Wenjuan Zeng; Qun Luo; Zhaoying Wang; Kui Wu; Jun Du; Fuyi Wang
Journal:  Front Chem       Date:  2020-04-28       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.